A detailed history of Eads & Heald Wealth Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Eads & Heald Wealth Management holds 20,236 shares of EW stock, worth $1.37 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
20,236
Previous 22,372 9.55%
Holding current value
$1.37 Million
Previous $2.07 Million 35.38%
% of portfolio
0.63%
Previous 1.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$59.7 - $93.78 $127,519 - $200,314
-2,136 Reduced 9.55%
20,236 $1.34 Million
Q2 2024

Jul 23, 2024

SELL
$84.3 - $94.31 $59,010 - $66,017
-700 Reduced 3.03%
22,372 $2.07 Million
Q1 2024

Apr 23, 2024

SELL
$72.54 - $95.56 $68,913 - $90,782
-950 Reduced 3.95%
23,072 $2.21 Million
Q4 2023

Jan 30, 2024

SELL
$61.71 - $77.76 $41,715 - $52,565
-676 Reduced 2.74%
24,022 $1.83 Million
Q3 2023

Oct 27, 2023

SELL
$69.28 - $93.38 $27,088 - $36,511
-391 Reduced 1.56%
24,698 $1.71 Million
Q2 2023

Jul 25, 2023

SELL
$81.41 - $94.33 $80,188 - $92,915
-985 Reduced 3.78%
25,089 $2.37 Million
Q1 2023

Apr 21, 2023

BUY
$74.26 - $84.51 $43,442 - $49,438
585 Added 2.3%
26,074 $2.16 Million
Q4 2022

Jan 27, 2023

BUY
$68.3 - $87.44 $86,809 - $111,136
1,271 Added 5.25%
25,489 $1.9 Million
Q3 2022

Oct 27, 2022

BUY
$82.37 - $107.29 $30,476 - $39,697
370 Added 1.55%
24,218 $2 Million
Q2 2022

Jul 26, 2022

SELL
$86.5 - $128.27 $11,591 - $17,188
-134 Reduced 0.56%
23,848 $2.27 Million
Q1 2022

Apr 27, 2022

SELL
$101.96 - $128.34 $46,901 - $59,036
-460 Reduced 1.88%
23,982 $2.82 Million
Q4 2021

Jan 31, 2022

SELL
$106.37 - $130.68 $40,207 - $49,397
-378 Reduced 1.52%
24,442 $3.17 Million
Q3 2021

Oct 27, 2021

SELL
$102.91 - $122.75 $239,471 - $285,639
-2,327 Reduced 8.57%
24,820 $2.81 Million
Q2 2021

Jul 30, 2021

SELL
$83.84 - $104.76 $90,463 - $113,036
-1,079 Reduced 3.82%
27,147 $2.81 Million
Q1 2021

Apr 29, 2021

BUY
$78.68 - $90.67 $18,411 - $21,216
234 Added 0.84%
28,226 $2.36 Million
Q4 2020

Feb 02, 2021

BUY
$71.69 - $91.23 $44,304 - $56,380
618 Added 2.26%
27,992 $2.55 Million
Q3 2020

Nov 02, 2020

SELL
$67.19 - $87.44 $212,857 - $277,009
-3,168 Reduced 10.37%
27,374 $2.18 Million
Q2 2020

Jul 29, 2020

BUY
$57.54 - $76.95 $1.17 Million - $1.57 Million
20,353 Added 199.75%
30,542 $2.11 Million
Q1 2020

May 01, 2020

SELL
$52.41 - $81.0 $4,769 - $7,371
-91 Reduced 0.89%
10,189 $640,000
Q4 2019

Jan 31, 2020

SELL
$71.7 - $82.09 $17,064 - $19,537
-238 Reduced 2.26%
10,280 $799,000
Q3 2019

Oct 31, 2019

SELL
$61.55 - $75.43 $28,066 - $34,396
-456 Reduced 4.16%
10,518 $770,000
Q2 2019

Jul 30, 2019

SELL
$55.74 - $64.41 $10,590 - $12,237
-190 Reduced 1.7%
10,974 $0
Q1 2019

Apr 26, 2019

SELL
$47.89 - $64.05 $50,715 - $67,828
-1,059 Reduced 8.66%
11,164 $0
Q4 2018

Jan 31, 2019

SELL
$46.41 - $56.94 $35,874 - $44,014
-773 Reduced 5.95%
12,223 $624,000
Q3 2018

Oct 31, 2018

SELL
$45.7 - $58.03 $12,064 - $15,319
-264 Reduced 1.99%
12,996 $0
Q2 2018

Jul 27, 2018

SELL
$42.45 - $51.3 $1,570 - $1,898
-37 Reduced 0.28%
13,260 $0
Q1 2018

Apr 26, 2018

BUY
$37.19 - $47.45 $74,380 - $94,900
2,000 Added 17.7%
13,297 $0
Q4 2017

Jan 31, 2018

BUY
$33.79 - $39.39 $132,794 - $154,802
3,930 Added 53.35%
11,297 $0
Q3 2017

Oct 27, 2017

BUY
$36.29 - $38.83 $267,348 - $286,060
7,367
7,367 $0

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Eads & Heald Wealth Management Portfolio

Follow Eads & Heald Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eads & Heald Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Eads & Heald Wealth Management with notifications on news.